Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rojas-García, R.
Right arrow Articles by Illa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rojas-García, R.
Right arrow Articles by Illa, I.
Related Collections
Right arrow Chronic inflammatory demyelinating polyneuropathy
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2003;61:1814-1816
© 2003 American Academy of Neurology
Brief Communications

Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximab

R. Rojas-García, MD, E. Gallardo, PhD, I. de Andrés, PhD, N. de Luna, PhD, C. Juarez, PhD, P. Sánchez, MD and I. Illa, MD

From the Department of Neurology, Neuromuscular Unit (Drs. Rojas-García, and Illa), Laboratory of Experimental Neurology (Drs. Gallardo, de Andrés, de Luna), and the Department of Immunology (Dr. Juarez), Hospital de la Sta Creu i St Pau and Institut de Recerca HSCSP, Universitat Autònoma de Barcelona; and Department of Neurology (Dr. Sánchez), Clínica Puerta de Hierro, Madrid, Spain.

Address correspondence and reprint requests to Dr. Isabel Illa, Department of Neurology, Hospital de Sant Pau, Padre Claret 167, 08025 Barcelona, Spain; e-mail: iilla{at}hsp.santpau.es

Two patients with chronic motor neuropathy, high antiganglioside antibody (AGA) titers, and a declining response to IV immunoglobulins were treated with rituximab at a standard dose. The drug was well tolerated and effectively eliminated peripheral B cells (CD20+), but AGA titers continued significantly high. No clinical improvement was detected during the 1-year follow-up.

Received February 25, 2003. Accepted in final form August 20, 2003.

Presented at the 54th annual meeting of the American Academy of Neurology; Denver, CO; 2002.




This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J M F Niermeijer, M Eurelings, H L Lokhorst, W-L van der Pol, H Franssen, J H J Wokke, and N C Notermans
Rituximab for polyneuropathy with IgM monoclonal gammopathy
J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 1036 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
M P T Lunn and H J Willison
Diagnosis and treatment in inflammatory neuropathies
Postgrad. Med. J., August 1, 2009; 85(1006): 437 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Neurological DisordersHome page
H. C. Lehmann, G. Meyer zu Horste, B. C. Kieseier, and H.-P. Hartung
Review: Pathogenesis and treatment of immune-mediated neuropathies
Therapeutic Advances in Neurological Disorders, July 1, 2009; 2(4): 261 - 281.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M P T Lunn and H J Willison
Diagnosis and treatment in inflammatory neuropathies
J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 249 - 258.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S D Arbogast, S Khanna, D W Koontz, R L Tomsak, B Katirji, and R J Leigh
Chronic ataxic neuropathy mimicking dorsal midbrain syndrome
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1276 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Renaud, P. Fuhr, M. Gregor, K. Schweikert, D. Lorenz, C. Daniels, G. Deuschl, A. Gratwohl, and A. J. Steck
High-dose rituximab and anti-MAG-associated polyneuropathy
Neurology, March 14, 2006; 66(5): 742 - 744.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
O. Stuve, S. Cepok, B. Elias, A. Saleh, H.-P. Hartung, B. Hemmer, and B. C. Kieseier
Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis
Arch Neurol, October 1, 2005; 62(10): 1620 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. J. Ruegg, P. Fuhr, and A. J. Steck
Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg
Neurology, December 14, 2004; 63(11): 2178 - 2179.
[Abstract] [Full Text] [PDF]